Proteome Sciences, Moffitt Collaborate on Mass Spec Assays for Cancer Studies
July 08, 2011
Proteome Sciences, Moffitt Collaborate on Mass Spec Assays for Cancer Studies
The work will focus on the development of mass spec assays for measuring signaling and repair pathway proteins for clinical tumor biopsy analysis.
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.
New to GenomeWeb? Register here quickly.
Related Stories
- Taking Aim at Clinical Oncology Market, Proteome Sciences Developing SRM-MS Assay for ER Status
July 22, 2011 / ProteoMonitor - Proteome Sciences Inks Deal with Eisai for First Commercial Use of Alzheimer's Biomarker Panel
February 4, 2011 / ProteoMonitor - Proteome Sciences and Icon Collaborate on Mass Spec Assays for Pharma Biomarker Development
November 19, 2010 / ProteoMonitor - Movers & Shakers
October 8, 2010 / ProteoMonitor - Proteome Sciences to Commercialize Two Protein Biomarker Assays for Alzheimer's Disease
July 16, 2010 / ProteoMonitor